DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
28
Frequently Asked Questions
What is Market Cap of DiaMedica Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. DiaMedica Therapeutics Inc market cap is $360.27M.
What is the 52-week high for DiaMedica Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. DiaMedica Therapeutics Inc 52 week high is $7.49 as of September 17, 2025.
What is the 52-week low for DiaMedica Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. DiaMedica Therapeutics Inc 52 week low is $3.19 as of September 17, 2025.
What is DiaMedica Therapeutics Inc stock price today?
DiaMedica Therapeutics Inc stock price today is $6.87.
What was DiaMedica Therapeutics Inc stock price yesterday?
DiaMedica Therapeutics Inc stock price yesterday was $6.97.
What is the PE ratio of DiaMedica Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. DiaMedica Therapeutics Inc’s P/E ratio is -10.10.
What is the Price-to-Book ratio of DiaMedica Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. DiaMedica Therapeutics Inc P/B ratio is 11.0495.
What is the 50-day moving average of DiaMedica Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. DiaMedica Therapeutics Inc 50-day moving average is $5.28.
How many employess does DiaMedica Therapeutics Inc has?